Literature DB >> 23549834

Extensive bullous complication associated with intermittent pneumatic compression.

Sung-Hun Won1, Young-Kyun Lee, You-Sung Suh, Kyung-Hoi Koo.   

Abstract

Intermittent pneumatic compression (IPC) device is an effective method to prevent deep vein thrombosis. This method has been known to be safe with very low rate of complications compared to medical thromboprophylaxis. Therefore, this modality has been used widely in patients who underwent a hip fracture surgery. We report a patient who developed extensive bullae, a potentially serious skin complication, beneath the leg sleeves during the use of IPC device after hip fracture surgery.

Entities:  

Keywords:  Venous thromboembolism; extensive bullae; fragile skin; intermittent pneumatic compression device

Mesh:

Year:  2013        PMID: 23549834      PMCID: PMC3635634          DOI: 10.3349/ymj.2013.54.3.801

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


INTRODUCTION

Intermittent pneumatic compression (IPC) device is an effective means to prevent deep vein thrombosis,1-4 and has been known to be safe with very low rate of complications compared to medical thromboprophylaxis.5 Therefore, this modality has been used widely in patients who underwent a hip fracture surgery.1-3,6 We report a patient who developed extensive bullae, a potentially serious skin complication, beneath the leg sleeves during the use of IPC device after hip fracture surgery.

CASE REPORT

An 81-year-old woman, who sustained an intertrochanteric fracture on her left hip, was admitted via emergency room. She had been medicated with a beta-blocker for the treatment of hypertension. Otherwise, she did not take any medicine including steroids or anti-platelet drugs. She had no history of skin allergies, and preoperative laboratory examination revealed no evidence of coagulopathy. She underwent a cementless bipolar hemiarthroplasty under a spinal anesthesia. No special event occurred during the operation. Postoperatively, IPC device (Kendall SCD EXPRESS™; Covidien, Mansfield, MA, USA) was applied on her both legs. According to a manufacture's brochure, the sleeve is made of a soft, lightweight, non-woven material, which can promote patient's comfort and compliance, and the microprocessor controls a 11-second-compression cycle to ensure 45 mm Hg-pressure delivery at the ankle, with resulting pressures of 40 mm Hg and 30 mm Hg sequentially at the calf and thigh. There were no special events during hip fracture surgery, and her vital signs were stable on immediate postoperative period. But the patient became delirious on postoperative day 1. On the postoperative day 3, when she recovered from the delirium, she complained of left leg pain, and extensive large bullous skin lesions were found in her left leg. The lesions developed circumferentially beneath the IPC sleeves (Fig. 1). On physical examination, distal pulses, sensation and motor function were intact.
Fig. 1

On the postoperative day 3, extensive large bullous skin lesions were found in her left leg.

Immediately after the detection of skin lesions, IPC device was removed. The patient was consulted to a dermatologist and a diagnosis of fragile skin was made. Hemorrhagic fluid was aspirated, and wet dressing was applied. After 7 days, the skin lesions improved and the hemorrhagic bullae disappeared.

DISCUSSION

Venous thromboembolism is a frequent and serious complication after hip fracture surgery in elderly patients. The IPC has been known to be effective in preventing venous thrombosis with far less morbidities than pharmacologic prophylaxis.5 Compartment syndrome due to malfunctioning sleeves or a prolonged use has been reported.7 However, no skin complication has been reported after the use of IPC so far. Our report showed that a bullous skin complication can occur even with recommended pressurization of 40-45 mm Hg during the use of IPC when the patient's skin is fragile. In our patient, the detection of the skin lesion was delayed by 2 or 3 days because the patient was delirious postoperatively. Delirium is commonly detected in elderly patients who underwent hip fracture surgery, that is characterized a change of mental status with attention, awareness deficits, and loss of cognitive and perceptive functions.8,9 When IPC device is applied on elderly patients with fragile skin and delirious condition, skin condition of the legs should be checked frequently during the application.
  9 in total

Review 1.  Delirium in the elderly patient.

Authors:  Z J Lipowski
Journal:  N Engl J Med       Date:  1989-03-02       Impact factor: 91.245

2.  A venous foot pump reduces thrombosis after total hip replacement.

Authors:  M J Fordyce; R S Ling
Journal:  J Bone Joint Surg Br       Date:  1992-01

3.  Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement.

Authors:  D Warwick
Journal:  J Bone Joint Surg Am       Date:  1998-01       Impact factor: 5.284

4.  Acute compartment syndrome caused by a malfunctioning pneumatic-compression boot. A case report.

Authors:  G B Werbel; G T Shybut
Journal:  J Bone Joint Surg Am       Date:  1986-12       Impact factor: 5.284

5.  A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

Authors:  K B Freedman; K R Brookenthal; R H Fitzgerald; S Williams; J H Lonner
Journal:  J Bone Joint Surg Am       Date:  2000-07       Impact factor: 5.284

6.  Clarifying confusion: the confusion assessment method. A new method for detection of delirium.

Authors:  S K Inouye; C H van Dyck; C A Alessi; S Balkin; A P Siegal; R I Horwitz
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

7.  Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.

Authors:  D Warwick; J Harrison; D Glew; A Mitchelmore; T J Peters; J Donovan
Journal:  J Bone Joint Surg Am       Date:  1998-08       Impact factor: 5.284

8.  Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial.

Authors:  R P Pitto; H Hamer; W Heiss-Dunlop; J Kuehle
Journal:  J Bone Joint Surg Br       Date:  2004-07

Review 9.  Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.

Authors:  H H Handoll; M J Farrar; J McBirnie; G Tytherleigh-Strong; A A Milne; W J Gillespie
Journal:  Cochrane Database Syst Rev       Date:  2002
  9 in total
  6 in total

Review 1.  [S1 guideline on intermittent pneumatic compression (IPC)].

Authors:  C Schwahn-Schreiber; F X Breu; E Rabe; I Buschmann; W Döller; G R Lulay; A Miller; E Valesky; S Reich-Schupke
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

2.  Wound complications after ankle surgery. Does compression treatment work? A randomized, controlled trial.

Authors:  Rikke Winge; Camilla Ryge; Lasse Bayer; Tobias Wirenfeldt Klausen; Hans Gottlieb
Journal:  Eur J Trauma Emerg Surg       Date:  2018-01-27       Impact factor: 3.693

3.  Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients.

Authors:  Woo-Lam Jo; Young-Kyun Lee; Yong-Chan Ha; Kyung-Min Lee; Bun-Jung Kang; Kyung-Hoi Koo
Journal:  J Korean Med Sci       Date:  2016-05-24       Impact factor: 2.153

4.  Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials.

Authors:  Jonghanne Park; Joo Myung Lee; Jeong Seok Lee; Young Jae Cho
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

5.  Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.

Authors:  Hong Suk Kwak; Jai Ho Cho; Jung Taek Kim; Jeong Joon Yoo; Hee Joong Kim
Journal:  Clin Orthop Surg       Date:  2017-02-13

6.  Letter to the editor. Folliculitis associated with intermittant pneumatic compression.

Authors:  Alparslan Bayram Çarlι; Erkan Kaya; Hasan Turgut; Mehmet Burak Selek
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.